BioCentury | May 23, 2020
Product Development

Hot topics at ASCO 2020

Center stage at this year’s virtual ASCO meeting are a series of hot topics that demonstrate the transformative potential of a single data readout or regulatory update. Areas to watch include next-generation checkpoint targets, where...
BC Innovations | Nov 2, 2016
Distillery Therapeutics


INDICATION: Parkinson’s disease (PD) In vitro and mouse studies suggest inhibiting LAG3 could help treat PD. In mouse primary cortical neurons treated with neurotoxic α-synuclein (SNCA) fibrils, LAG3 knockout or two anti-LAG3 mouse antibodies decreased...
BC Week In Review | Oct 10, 2016
Company News

Boehringer Ingelheim, Sarah Cannon Research Institute deal

Boehringer and the institute partnered to develop Boehringer’s BI 754091 in combination with BI 754111 to treat cancer, including non-small cell lung cancer (NSCLC). BI 754091 is a mAb against PD-1 , and BI 754111 is...
Items per page:
1 - 3 of 3